Herceptin Research Today is a free monthly online journal that collates and summarizes the latest research about Herceptin, including details on side-effects, breast cancer, treatment, therapy.

Volume 2 (2005), Issue 9 (September)

1. Unknown primary carcinoma, diagnosed as inflammatory breast cancer,and successfully treated with trastuzumab and vinorelbine.
   Int J Clin Oncol, 10(4): 285-8. [Abstract] [Full-text]
2. The interstitial distribution of macromolecules in rat tumours is influenced by the negatively charged matrix components.
   J Physiol, 567: 557-67. [Abstract] [Full-text]
3. Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2.
   Clin Cancer Res, 11(17): 6382-9. [Abstract] [Full-text]
4. Monoclonal antibody therapy of cancer.
   Nat Biotechnol, 23(9): 1147-57. [Abstract] [Full-text]
5. In vitro and in vivo Effects of Combination of Trastuzumab (Herceptin) and Tamoxifen in Breast Cancer.
   Breast Cancer Res Treat, 92(3): 251-263. [Abstract] [Full-text]
6. Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells.
   Oncogene, 24(41): 6213-21. [Abstract] [Full-text]
7. Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials.
   Clin Cancer Res, 11(18): 6598-607. [Abstract] [Full-text]
8. Trastuzumab therapy for tamoxifen-stimulated endometrial cancer.
   Cancer Res, 65(18): 8504-13. [Abstract] [Full-text]
9. Blockade of epidermal growth factor receptors chemosensitizes breast cancer cells through up-regulation of Bnip3L.
   Cancer Res, 65(18): 8151-7. [Abstract] [Full-text]
10. Combined radioimmunotherapy and chemotherapy of breast tumors with Y-90-labeled anti-Her2 and anti-CEA antibodies with taxol.
    Bioconjug Chem, 16(5): 1117-25. [Abstract] [Full-text]
11. Determination of HER2 Gene Amplification by Fluorescence In situ Hybridization and Concordance with the Clinical Trials Immunohistochemical Assay in Women with Metastatic Breast Cancer Evaluated for Treatment with Trastuzumab.
    Breast Cancer Res Treat, 93(1): 3-11. [Abstract] [Full-text]
12. Signal transduction of erbB receptors in trastuzumab (Herceptin) sensitive and resistant cell lines: Local stimulation using magnetic microspheres as assessed by quantitative digital microscopy.
    Cytometry A, 67(2): 161-71. [Abstract] [Full-text]
13. C-erb-B2 (HER2/neu) expression in synovial sarcoma of the head and neck.
    Head Neck, 27(10): 883-92. [Abstract] [Full-text]
14. Cripto monoclonal antibodies.
    Drug News Perspect, 18(5): 293-303. [Abstract] [Full-text]
15. Her-2 Oncogene Amplification, Chromosome 17 and DNA Ploidy Status in Synovial Sarcoma.
    Pathol Oncol Res, 11(3): 133-138. [Abstract] [Full-text]

© 2004-2008 Herceptin Research Today. All Rights Reserved.